Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Feb 2022 – 20 Aug 2026, limited by Axis Nifty Next 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty Next 50 Index Fund | Nifty 50 |
|---|---|---|
| 02 Feb 2022 | ₹100.00 | ₹100.00 |
| 20 Jun 2022 | ₹84.03 | ₹86.33 |
| 06 Nov 2022 | ₹102.51 | ₹101.90 |
| 24 Mar 2023 | ₹89.17 | ₹95.30 |
| 09 Aug 2023 | ₹106.58 | ₹110.42 |
| 26 Dec 2023 | ₹124.09 | ₹120.59 |
| 12 May 2024 | ₹151.16 | ₹124.04 |
| 27 Sep 2024 | ₹183.26 | ₹147.24 |
| 13 Feb 2025 | ₹143.59 | ₹129.54 |
| 01 Jul 2025 | ₹162.13 | ₹143.65 |
| 16 Nov 2025 | ₹164.20 | ₹145.73 |
| 04 Apr 2026 | ₹145.81 | ₹127.75 |
| 20 Aug 2026 | ₹174.57 | ₹136.29 |
| Metric | Axis · Regular NAV ₹17.86 Very High risk ★★★☆☆ | Category median Index Funds · 366 funds |
|---|---|---|
| +8.69% | +5.43% | |
| +18.95% | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +13.04% | +7.40% | |
| +14.41% | — | |
| +17.90% | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 18.25% | 13.88% | |
| 0.68 | 0.25 | |
| 0.92 | 0.35 | |
| -26.59% | -16.66% | |
| Nifty 50 | — | |
| +9.61% | +0.30% | |
| 1.30 | 1.00 | |
| 141.7% | 101.3% | |
| 97.0% | 98.8% | |
| 1.13% | 0.96% | |
| ₹481.51Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 35% | |
| Karthik Kumar | — | |
| 02 Feb 2022 | — | |
| 50 | — | |
| 32.2% | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.